electroCore Inc ECOR
News
electroCore to Participate in the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum
electroCore Announces Third Quarter 2026 Financial Results
electroCore to Announce Third Quarter September 30, 2026, Financial Results on Wednesday, November 4, 2026
electroCore, Inc. Submits 510(k) Premarket Notification to FDA Seeking Clearance of Quell® for the Treatment of Chronic Chemotherapy-Induced Peripheral Neuropathy (CIPN)
fMRI Study Suggests Transcutaneous Cervical Vagus Nerve Stimulation (tcVNS) Accelerates Neural Processes in Visual Skill Learning
electroCore to Present at Planet MicroCap Toronto 2026 powered by MicroCapClub
electroCore to Participate at H.C. Wainwright Global Investment Conference
electroCore, Inc. Appoints Joshua Lev and Mike Fox as Co-Chief Executive Officers
electroCore’s Truvaga® Named Best Luxury Biohacking & Longevity Brand in the USA by Luxury Lifestyle Awards
